PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer

Seema Parte, Irma Virant-Klun, Manish Patankar, Surinder K. Batra, Alex Straughn, Sham S. Kakar

Research output: Contribution to journalArticle

Abstract

Origin of cancer stem cells (CSCs) and mechanisms by which oncogene PTTG1 contributes to tumor progression via CSCs is not known. Ovarian CSCs exhibit characteristics of self-renewal, tumor-initiation, growth, differentiation, drug resistance, and tumor relapse. A common location of putative origin, namely the ovarian surface epithelium, is shared between the normal stem and CSC compartments. Existence of ovarian stem cells and their co-expression with CSC signatures suggests a strong correlation between origin of epithelial cancer and CSCs. We hereby explored a putative oncogene PTTG1 (Securin), reported to be overexpressed in various tumors, including ovarian. We report a previously overlooked role of PTTG1 as a marker of CSCs thereby modulating CSC, germline, and stemness-related genes. We further characterized PTTG1’s ability to regulate (cancer) stem cell-associated self-renewal and epithelial-mesenchymal transition pathways. Collectively, the data sheds light on a potential target expressed during ovarian tumorigenesis and metastatically disseminated ascites CSCs in the peritoneal cavity. Present study highlights this unconventional, under-explored role of PTTG1 in regulation of stem and CSC compartments in ovary, ovarian cancer and ascites and highlights it as a potential candidate for developing CSC specific targeted therapeutics.

Original languageEnglish (US)
Pages (from-to)866-879
Number of pages14
JournalStem Cell Reviews and Reports
Volume15
Issue number6
DOIs
StatePublished - Dec 1 2019

Fingerprint

Neoplastic Stem Cells
Ovarian Neoplasms
Neoplasms
Oncogenes
Ascites
Securin
Epithelial-Mesenchymal Transition
Peritoneal Cavity
Drug Resistance
Carcinogenesis
Stem Cells
Epithelium

Keywords

  • Cancer stem cells
  • Oncogene
  • Ovarian cancer
  • Ovary
  • PTTG1
  • Securin
  • Stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

PTTG1 : a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer. / Parte, Seema; Virant-Klun, Irma; Patankar, Manish; Batra, Surinder K.; Straughn, Alex; Kakar, Sham S.

In: Stem Cell Reviews and Reports, Vol. 15, No. 6, 01.12.2019, p. 866-879.

Research output: Contribution to journalArticle

Parte, Seema ; Virant-Klun, Irma ; Patankar, Manish ; Batra, Surinder K. ; Straughn, Alex ; Kakar, Sham S. / PTTG1 : a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer. In: Stem Cell Reviews and Reports. 2019 ; Vol. 15, No. 6. pp. 866-879.
@article{352e15e59e764a68beaf3f247d51b111,
title = "PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer",
abstract = "Origin of cancer stem cells (CSCs) and mechanisms by which oncogene PTTG1 contributes to tumor progression via CSCs is not known. Ovarian CSCs exhibit characteristics of self-renewal, tumor-initiation, growth, differentiation, drug resistance, and tumor relapse. A common location of putative origin, namely the ovarian surface epithelium, is shared between the normal stem and CSC compartments. Existence of ovarian stem cells and their co-expression with CSC signatures suggests a strong correlation between origin of epithelial cancer and CSCs. We hereby explored a putative oncogene PTTG1 (Securin), reported to be overexpressed in various tumors, including ovarian. We report a previously overlooked role of PTTG1 as a marker of CSCs thereby modulating CSC, germline, and stemness-related genes. We further characterized PTTG1’s ability to regulate (cancer) stem cell-associated self-renewal and epithelial-mesenchymal transition pathways. Collectively, the data sheds light on a potential target expressed during ovarian tumorigenesis and metastatically disseminated ascites CSCs in the peritoneal cavity. Present study highlights this unconventional, under-explored role of PTTG1 in regulation of stem and CSC compartments in ovary, ovarian cancer and ascites and highlights it as a potential candidate for developing CSC specific targeted therapeutics.",
keywords = "Cancer stem cells, Oncogene, Ovarian cancer, Ovary, PTTG1, Securin, Stem cells",
author = "Seema Parte and Irma Virant-Klun and Manish Patankar and Batra, {Surinder K.} and Alex Straughn and Kakar, {Sham S.}",
year = "2019",
month = "12",
day = "1",
doi = "10.1007/s12015-019-09911-5",
language = "English (US)",
volume = "15",
pages = "866--879",
journal = "Stem Cell Reviews and Reports",
issn = "1550-8943",
publisher = "Humana Press",
number = "6",

}

TY - JOUR

T1 - PTTG1

T2 - a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer

AU - Parte, Seema

AU - Virant-Klun, Irma

AU - Patankar, Manish

AU - Batra, Surinder K.

AU - Straughn, Alex

AU - Kakar, Sham S.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Origin of cancer stem cells (CSCs) and mechanisms by which oncogene PTTG1 contributes to tumor progression via CSCs is not known. Ovarian CSCs exhibit characteristics of self-renewal, tumor-initiation, growth, differentiation, drug resistance, and tumor relapse. A common location of putative origin, namely the ovarian surface epithelium, is shared between the normal stem and CSC compartments. Existence of ovarian stem cells and their co-expression with CSC signatures suggests a strong correlation between origin of epithelial cancer and CSCs. We hereby explored a putative oncogene PTTG1 (Securin), reported to be overexpressed in various tumors, including ovarian. We report a previously overlooked role of PTTG1 as a marker of CSCs thereby modulating CSC, germline, and stemness-related genes. We further characterized PTTG1’s ability to regulate (cancer) stem cell-associated self-renewal and epithelial-mesenchymal transition pathways. Collectively, the data sheds light on a potential target expressed during ovarian tumorigenesis and metastatically disseminated ascites CSCs in the peritoneal cavity. Present study highlights this unconventional, under-explored role of PTTG1 in regulation of stem and CSC compartments in ovary, ovarian cancer and ascites and highlights it as a potential candidate for developing CSC specific targeted therapeutics.

AB - Origin of cancer stem cells (CSCs) and mechanisms by which oncogene PTTG1 contributes to tumor progression via CSCs is not known. Ovarian CSCs exhibit characteristics of self-renewal, tumor-initiation, growth, differentiation, drug resistance, and tumor relapse. A common location of putative origin, namely the ovarian surface epithelium, is shared between the normal stem and CSC compartments. Existence of ovarian stem cells and their co-expression with CSC signatures suggests a strong correlation between origin of epithelial cancer and CSCs. We hereby explored a putative oncogene PTTG1 (Securin), reported to be overexpressed in various tumors, including ovarian. We report a previously overlooked role of PTTG1 as a marker of CSCs thereby modulating CSC, germline, and stemness-related genes. We further characterized PTTG1’s ability to regulate (cancer) stem cell-associated self-renewal and epithelial-mesenchymal transition pathways. Collectively, the data sheds light on a potential target expressed during ovarian tumorigenesis and metastatically disseminated ascites CSCs in the peritoneal cavity. Present study highlights this unconventional, under-explored role of PTTG1 in regulation of stem and CSC compartments in ovary, ovarian cancer and ascites and highlights it as a potential candidate for developing CSC specific targeted therapeutics.

KW - Cancer stem cells

KW - Oncogene

KW - Ovarian cancer

KW - Ovary

KW - PTTG1

KW - Securin

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85072191502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072191502&partnerID=8YFLogxK

U2 - 10.1007/s12015-019-09911-5

DO - 10.1007/s12015-019-09911-5

M3 - Article

C2 - 31482269

AN - SCOPUS:85072191502

VL - 15

SP - 866

EP - 879

JO - Stem Cell Reviews and Reports

JF - Stem Cell Reviews and Reports

SN - 1550-8943

IS - 6

ER -